Skip to content

Endometrial Fluid Study in Natural Cycles: a Prospective Observational Study

Endometrial Fluid Study in Natural Cycles: a Prospective Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03909230
Enrollment
30
Registered
2019-04-09
Start date
2019-04-02
Completion date
2019-05-27
Last updated
2021-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial Fluid

Brief summary

This study is designed to collect information about the characteristics of endometrial fluid at day 2 and day 4 post-ovulation in normal fertile women.

Detailed description

Implantation rates have stabilised around 35% in IVF and a current key rate limiting step is achieving successful implantation of the embryo. 1/3 of implantation failures are estimated to be caused by a problem with the receptivity of the endometrium. In recent years, several measurable parameters have been reported to assess endometrial receptivity. However, one parameter remains undescribed, the endometrial fluid viscosity. It is generally believed that the viscosity change post ovulation is influenced by the luteal phase endocrine milieu, and it is possible that the viscosity of the endometrial fluid has an impact on implantation.

Interventions

None listed

Sponsors

Anecova SA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
No minimum to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Age: ≤ 35 years * Women eligible and qualified for egg donation at IVIRMA Bilbao * Proven fertile (having given birth to at least one spontaneously conceived normal child) * Signed written consent including sharing of anonymized data

Exclusion criteria

* Contraindications for egg donation according to IVIRMA Bilbao guidelines

Design outcomes

Primary

MeasureTime frame
Viscosity of endometrial fluid at D2 and D4 post ovulation of the normal cycle, respectively4 days

Secondary

MeasureTime frame
Plasma progesterone level4 days
Plasma estradiol (E2) level4 days
Endometrial thickness as measured by ultrasound4 days

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026